Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus-A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial

被引：2
|
作者：
Dandona, Paresh
Ghanim, Husam
Kuhadiya, Nitesh D.
Shah, Tanvi
Hejna, Jeanne M.
Makdissi, Antoine
Batra, Manav
Chaudhuri, Ajay
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-3-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Liraglutide as Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus: A Randomized Clinical Trial
    Kuhadiya, Nitesh D.
    Dhindsa, Sandeep
    Makdissi, Antoine
    Ghanim, Husam A.
    Batra, Manav
    Chaudhuri, Ajay
    Hejna, Jeanne
    Green, Kelly
    Bellini, Natalie
    Dandona, Paresh
    DIABETES, 2014, 63 : A250 - A250
  • [2] Liraglutide As Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus: A Randomized Clinical Trial
    Kuhadiya, Nitesh D.
    Dhindsa, Sandeep S.
    Mehta, Aditya
    Makdissi, Antoine
    Sandhu, Sartaj
    Ghanim, Husam
    Batra, Manav
    Chaudhuri, Ajay
    Hejna, Jeanne
    Green, Kelly
    Bellini, Natalie
    Dandona, Paresh
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] Cardiovascular effects of liraglutide in patients with type 1 diabetes: a randomised, double-blinded placebo-controlled trial (Lira-1)
    Dejgaard, T. F.
    Johansen, N. B.
    Frandsen, C. S.
    Asmar, A.
    Tamrow, L.
    Knop, F. K.
    Madsbad, S.
    Andersen, H. U.
    DIABETOLOGIA, 2016, 59 : S356 - S357
  • [4] Synbiotics and Treatment of Asthma: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
    Hassanzad, Maryam
    Mostashari, Keyvan Maleki
    Ghaffaripour, Hosseinali
    Emami, Habib
    Limouei, Samane Rahimi
    Velayati, Ali Akbar
    GALEN MEDICAL JOURNAL, 2019, 8
  • [5] Intravenous Immunoglobulin for Treatment of Demyelinating Polyneuropathy in Patients with Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial
    Breiner, Ari
    Tapia, Carolina Barnett
    Lovblom, Leif Erik
    Perkins, Bruce
    Katzberg, Hans
    Bril, Vera
    NEUROLOGY, 2019, 92 (15)
  • [6] Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks
    Kuhadiya, Nitesh D.
    Dhindsa, Sandeep
    Ghanim, Husam
    Mehta, Aditya
    Makdissi, Antoine
    Batra, Manav
    Sandhu, Sartaj
    Hejna, Jeanne
    Green, Kelly
    Bellini, Natalie
    Yang, Min
    Chaudhuri, Ajay
    Dandona, Paresh
    DIABETES CARE, 2016, 39 (06) : 1027 - 1035
  • [7] Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
    Thalange, N.
    Bereket, A.
    Larsen, J.
    Hiort, L. C.
    Peterkova, V.
    DIABETIC MEDICINE, 2013, 30 (02) : 216 - 225
  • [8] Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
    Maryana Savytska
    Dmytro Kyriienko
    Iuliia Komisarenko
    Oleksandr Kovalchuk
    Tetyana Falalyeyeva
    Nazarii Kobyliak
    Diabetes Therapy, 2023, 14 : 1915 - 1931
  • [9] Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo-controlled double-blinded clinical trial
    Leong, Pui-Ying
    Chen, Huang-Hsi
    Gau, Shuo-Yan
    Chen, Chia-Yin
    Su, Yi-Chang
    Wei, James Cheng-Chung
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [10] Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial
    Foghsgaard, Signe
    Vedtofte, Louise
    Andersen, Emilie S.
    Bahne, Emilie
    Andreasen, Camilla
    Sorensen, Anne L.
    Forman, Julie L.
    Mathiesen, Elisabeth R.
    Svare, Jens A.
    Clausen, Tine D.
    Damm, Peter
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 201 - 214
12345